Autonomic mechanisms and therapeutic implications of postural diabetic Cardiovascular abnormalities

Journal of Diabetes Science and Technology

Volumn 2, Issue 4, 2008, Pages 645-657

  Arora, Rohit R ^a   Bulgarelli, Robert J ^b   Ghosh Dastidar, Samanwoy ^c   Colombo, Joseph ^c  

^a The Chicago Medical College   (United States)

^b Riddle Memorial Hospital   (United States)

^c Ansar Inc   (United States)

Author keywords

Autonomic nervous system; Cardiovascular autonomic neuropathy; Orthostatic hypotension; Postural orthostatic tachycardia syndrome; Respiratory activity analysis; Vasopressor

Indexed keywords

EID: 77956172128     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680800200416     Document Type: Article

References (43)

1. Vinik AI, Freeman R, Erbas T. Diabetic autonomic neuropathy. Semin Neurol. 2003;23(4):365-72.
2. Vinik AI, Aysin B, Colombo J. Dynamic enhanced frequency domain analysis indicates a significant decline in autonomic function before age 50. Diabetes Technology Conference; 2005 Nov. 10-12; San Francisco, CA.
3. Vinik AI, Aysin B, Colombo J. Differentiation of autonomic dysfunction by enhanced frequency domain analysis reveals additional stages in the progression of autonomic decline in diabetics. Diabetes Technology Conference; 2005 Nov. 10-12; San Francisco, CA.
4. Freeman R. Assessment of cardiovascular autonomic function. Clin Neurophysiol. 2006;117(4):716-30.
5. Vinik AI, Freeman R, Erbas T. Diabetic autonomic neuropathy. Semin Neurol. 2003;23(4):365-72.
6. Boulton A J M, Vinik AI, Arezzo JC, Bril V, Feldman EI, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D; American Diabetes Association. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 28(4):956-62.
7. Joint Editorial Statement by the American Diabetes Association; the National Heart, Lung, and Blood Institute; the Juvenile Diabetes Foundation International; the National Institute of Diabetes and Digestive and Kidney Diseases; and the American Heart Association. Diabetes mellitus: a major risk factor for cardiovascular disease. Circulation. 1999;100(13):1132-3.
8. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC Jr, Sowers JR. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;100(13):1134-46.
9. Freeman R. Treatment of orthostatic hypotension. Semin Neurol. 2003;23(4):435-42.
10. Maser RE, Lenhard MJ. Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment. J Clin Endocrinol Metab. 2005;90(10):5896-903.
11. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115(3):387-97.
12. Aysin B, Aysin E, Colombo J, Vinik A. Diabetes may accelerate the onset of orthostasis. 6th Annual Diabetes Technology Meeting; 2006 Nov. 2-6; Atlanta, GA.
13. Stoupakis G, Colombo J, Rendas-Baum R, Budhwani N, Arora R. Postural drop of low frequency component of heart rate variability in the diagnosis of orthostasis. AHA Abstr., Chicago, IL; 2002.
14. Arora RR, Aysin E, Aysin B, Colombo J. Therapeutic implications of sympathetic stimulus in orthostatic patients: measured by spectral domain analysis. AHA Scientific Sessions; 2007 Nov. 4-7; Orlando, FL.
15. Borst C, Weiling W, van Brederode JF, Hond A, de Rijk LG, Dunning AJ. Mechanisms of initial heart rate response to postural change. Am J Physiol. 1982;243(5):H676-81.
16. Smit AA, Halliwill JR, Low PA, Wieling W. Pathophysiological basis of orthostatic hypotension in autonomic failure. J Physiol. 1999;519 Pt 1:1-10.
17. Vinik AI, Maser RE, Nakave AA. Diabetic cardiovascular autonomic nerve dysfunction. US Endocr Dis. 2007; Dec: 2-9.
18. Assessment: Clinical autonomic testing report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 1996;46(3):873-80.
19. Aring AM, Jones DE, Falko JM. Evaluation and prevention of diabetic neuropathy. Am Fam Physician. 2005;71(11):2123-30.
20. Bradley JG, Davis KA. Orthostatic hypotension. Am Fam Physician. 2003;68(12):2393-8.
21. Streeten DH, Auchincloss JH Jr, Anderson GH Jr, Richardson RL, Thomas FD, Miller JW. Orthostatic hypertension. Pathogenetic studies. Hypertension. 1985;7(2):196-203.
22. Yoshinari M, Wakisaka M, Nakamura U, Yoshioka M, Uchizono Y, Iwase M. Orthostatic hypertension in patients with type 2 diabetes. Diabetes Care. 2001;24(10):1783-6.
23. Vinik AI, Aysin B, Colombo J. Enhanced frequency domain analysis replaces older heart rate variability methods. Fourth Annual Diabetes Technology Meeting; 2004 Oct. 28-30.
24. Low PA. Testing the autonomic nervous system. Semin Neurol. 2003;23(4):407-21.
25. Low PA. Clinical autonomic disorders. 2nd ed. Philadelphia, PA: Lippincott Press; 1997. p 396.
26. Bloomfield DM, Kaufman ES, Bigger JT Jr, Fleiss J, Rolnitzky L, Steinman R. Passive head-up tilt and actively standing up produce similar overall changes in autonomic balance. Am Heart J. 1997;134(2 Pt 1):316-20.
27. Maule S, Catalfamo E, Del Colle S, Leotta G, Caserta M, Tredici M, Rabbia F, Veglio F. Cardiovascular autonomic function in 422 patients with orthostatic symptoms. Am J Hypertens. 2003;16:505.
28. Malik M. Clinical guide to cardiac autonomic tests. The Netherlands: Kluwer Academic Publishers; 1998.
29. Malik M, Camm AJ. Heart rate variability. Armonk, NY: Futura Press; 1995.
30. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability, standards of measurement, physiological interpretation, and clinical use. Circulation. 1996;93(5):1043-65.
31. Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger AC, Cohen RJ. Power spectrum analysis of heart fuctuations: a quantitative probe of beat to beat cardiovascular control. Science. 1981;213(4504):220-2.
32. Akselrod S, Gordon D, Madwed JB, Snidman NC, Shannon DC, Cohen RJ. Hemodynamic regulation: investigation by spectra analysis. Am J Physiol. 1985;249(4 Pt 2):H867-75.
33. Akselrod S, Eliash S, Oz O, Cohen S. Hemodynamic regulation in SHR: investigation by spectral analysis. Am J Physiol. 1987;253(1 Pt 2):H176-83.
34. Akselrod S. Spectral analysis of fuctuations in cardiovascular parameters: a quantitative tool for the investigation of autonomic control. Trends Pharmacol Sci. 1988;9(1):6-9.
35. Uijtdehaage SH, Thayer JF. Accentuated antagonism in the control of human heart rate. Clin Auton Res. 2000;10(3):107-10.
36. Williams CA, Lopes P. The Influence of ventilatory control on heart rate variability in children. J Sports Sci. 2002;20(5):407-15.
37. Cammann H, Michel J. How to avoid misinterpretation of heart rate variability power spectra? Comput Methods Programs Biomed. 2002;68(1):15-23
38. Vinik AI, Arora RR, Maser RE, Ghosh-Dastidar S, Colombo J. ß1-adrenergic antagonists change sympathovagal balance in diabetics. US Endocr Disease. Submitted.
39. Vinik AI, Aysin B, Colombo J. Enhanced frequency domain analysis identifes early autonomic dysfunction that may lead to elevated blood pressure in diabetics. Diabetes Technology Conference; 2005 Nov. 10-12; San Francisco, CA.
40. Young TM, Mathias CJ. The effects of water ingestion on orthostatic hypotension in two groups of chronic autonomic failure: multiple system atrophy and pure autonomic failure. J Neurol Neurosurg Psychiatry. 2004;75(12):1737-41.
41. Gibbons CH, Freeman R. Treatment options for autonomic neuropathies. Curr Treat Options Neurol. 2006;8(2):119-32.
42. Sandroni P, Opfer-Gehrking, Singer W, Low PA. Pyridostigmine for treatment of neurogenic orthostatic hypotension [correction of hypertension]-a follow-up survey study. Clin Auton Res. 2005;15(1):51-3.
43. Aysin B, Aysin E, Colombo J, Vinik A. Comparison of HRV analysis methods during orthostatic challenge: HRV with respiration or without? IEEE Engineering in Medicine and Biology Conference; Lyons, France; 2007.